These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12775016)

  • 1. Longterm control of advanced and recurrent gastric cancer (ARGC) by S-1.
    Cho H; Konishi K; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Imada T
    Gastric Cancer; 2003; 6 Suppl 1():24-7. PubMed ID: 12775016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.
    Tsujitani S; Fukuda K; Kaibara N
    Gastric Cancer; 2003; 6 Suppl 1():50-7. PubMed ID: 12775021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects.
    Takahashi I; Kakeji Y; Emi Y; Sakurai M; Yonemura Y; Kimura Y; Maehara Y
    Gastric Cancer; 2003; 6 Suppl 1():28-33. PubMed ID: 12775017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
    Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new regimen for S-1 therapy aiming at adverse reaction mitigation and prolonged medication by introducing a 1-week drug-free interval after each 2-week dosing session: efficacy and feasibility in clinical practice.
    Kimura Y; Kikkawa N; Iijima S; Kato T; Naoi Y; Hayashi T; Tanigawa T; Yamamoto H; Kurokawa E
    Gastric Cancer; 2003; 6 Suppl 1():34-9. PubMed ID: 12775018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey.
    Kawai H; Ohtsu A; Boku N; Hamamoto Y; Nagashima F; Muto M; Sano Y; Mera K; Yano T; Doi T; Yoshida S
    Gastric Cancer; 2003; 6 Suppl 1():19-23. PubMed ID: 12775015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.
    Baba H; Yamamoto M; Endo K; Ikeda Y; Toh Y; Kohnoe S; Okamura T
    Gastric Cancer; 2003; 6 Suppl 1():45-9. PubMed ID: 12775020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients.
    Sakata Y; Ohtsu A; Horikoshi N; Sugimachi K; Mitachi Y; Taguchi T
    Eur J Cancer; 1998 Oct; 34(11):1715-20. PubMed ID: 9893658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A clinical results of TS-1 in advanced and recurrent gastric cancer in our hospital].
    Abe S; Kojima M; Tamura H; Kurihara H; Kitago M; Kobayashi T; Nakamura T; Ogihara T
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):963-70. PubMed ID: 12894711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate-day oral therapy with TS-1 for advanced gastric cancer.
    Arai W; Hosoya Y; Hyodo M; Yokoyama T; Hirashima Y; Yasuda Y; Nagai H; Shirasaka T
    Int J Clin Oncol; 2004 Jun; 9(3):143-8. PubMed ID: 15221596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of a combination of s-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Ueda Y; Yamagishi H; Ichikawa D; Morii J; Koizumi K; Kakihara N; Shimotsuma M; Takenaka A; Yamashita T; Kurioka H; Nishiyama M; Morita S; Nakamura K; Sakamoto J
    Oncology; 2005; 69(3):261-8. PubMed ID: 16138002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful treatment of gastric cancer accompanied by multiple liver metastases with TS-1 followed by curative gastrectomy affiliation].
    Inoue S; Umekita N; Kitamura M
    Gan To Kagaku Ryoho; 2002 Jun; 29(6):939-42. PubMed ID: 12090048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new therapeutic approach to advanced and recurrent gastric cancer by TS-1].
    Yoshida K; Nishimoto N; Kagawa Y; Hihara J; Inoue H; Kim R; Hirai T; Nishiyama M; Toge T
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1403-12. PubMed ID: 11681248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of advanced gastric cancer effectively treated by TS-1 for 4 years].
    Ogino H; Misawa T; Nasu T; Ihara Y; Kubo S; Sadamoto Y; Harada N; Nakamura K
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):833-6. PubMed ID: 15984526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
    Fushida S; Fujimura T; Oyama K; Yagi Y; Kinoshita J; Ohta T
    Anticancer Drugs; 2009 Sep; 20(8):752-6. PubMed ID: 19543076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.
    Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K
    Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation, including QOL of TS-1 for patients with locally advanced or recurrent gastric cancer at ambulatory setting].
    Oeda M; Hirabayashi N; Takiyama W; Nagamine I; Ohara M; Oshita A; Satou Y; Saeki S; Kirihara Y; Mukaida H; Hisamatu K
    Gan To Kagaku Ryoho; 2003 Oct; 30(10):1453-8. PubMed ID: 14584277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.
    Cui Y; Li Q; Yu Y; Chen Y; Feng Y; Wang Y; Liu T
    Cancer Chemother Pharmacol; 2013 Jan; 71(1):145-52. PubMed ID: 23064955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I study of S-1 in combination with nab-paclitaxel in patients with unresectable or recurrent gastric cancer.
    Nakayama N; Ishido K; Chin K; Nishimura K; Azuma M; Matsusaka S; Inokuchi Y; Tanabe S; Kumekawa Y; Koizumi W
    Gastric Cancer; 2017 Mar; 20(2):350-357. PubMed ID: 27189323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical effect of TS-1 in advanced and recurrent gastric cancer with peritoneal dissemination].
    Inaba Y; Watabe S; Ohe S; Kamio Y; Koyama M; Hayashi K; Chiba M
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):239-44. PubMed ID: 11865630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.